Lilly receives FDA approval for rare blood cancer treatment

Please subscribe to IBJ to decode this article.

eiF A robIyasft sasL irefai d iEs ar Cccgduo .apeuehhUieh art a m deaTym r toJ aa wpaots2ndrvlDevt e no.t lmwd’nsii rolMnemhoremarrop alcmdtdl ot-udtecumn aea Crroacf s aslA roahSliyltntF ardpoflry t vse Dif de1ph A ae.tl pre.e i eApnrd ntatre r hpasdlae a os owapsldFytelaPyp sanhL rdnr, ooaibspd/eptynu.uo

boae shcy f ictrpnirr e aecey sane0s aio 0eg ef,leeduth i i n r ilLocmn hllwoCrecstrdlinlee0 os0e ch bpotltediarobsoaet hdh huiydah1.e stha c oonra law2d LnMec0ri r od sp .t,tawcofiTslew t

p nat datai mosr n o Jenc hKre pypiKmilt , iiteeaoy’ whhf s clewsvatc h armu.nErBoiTnosotinr eleym sainlicat toyiiys f oeesTcla,r@io t,hoeini it,hnt tociLexsiL eo aetrgahnies obu,pu lnyslaehB. uynttlgnidters Li hraLois atonlkalsls incBihdC s i otd ts yrbnearpesioeoviieTeni pe phn tMfis abeed ttnti

0oma2sogclhseoR yreoe. ,altd0sa1t heb0igfmeresep $sfot, ir0y uae 2hl etrdeoe ndceT,3r tmdaw twta rhu ,teplkJt 0 e0hrl

a Ltsf nwAmao tnt tMrm lteeonlP nlya ta f aea hCne hoeraxa ned iilCCls dw Umnru ,g anwpsnsotham synneaehia o volnvhmtn ocoa m dl ,sa ari ea oo ecrotskDievt pod.rsrne shan isvdddaeortri rsdiils tf eighsehspaeo diiefnTprr enn snrtap a .harMnigeopWEdvloyuioMlrcan ptffi e tiaDcP ftred aomeToeaetp ooooiyrtneo pL i

i tekei evet h nieinit asax honalkd teesam nppm.lcaUstlwic Setr Jeoty Lbayalec ig

Me tecliloosr ore eyt h iC wowwon“ aadahbtot dL mtlae splndmhmtp, ealcf a nil linawnenrineth”tiCar ,osa fot oenid a tieotaioyotReMvrrLioetrsha meitege cuFeihiwah nrtro.enor ni,taa pfTrf ni n wK ynawa h bigoai.po pr n ”atf,w n vsirpcn gtphreo zOuMtneGe rr t“ ahEi,oppsb coTewhnndee the aslhgeegthwd BpeCrmhlevpeULJvon, tar

pf c ritBiinntouclllsae p.eev afaceeeren m tanL cdnorlpefmeitoneeiihoctliadesf lo vop cda invuoa,eairorcnyn na r groeaadtflooort tutnt ici nbnmhdiytre i ciaaa rpt fnlpsb tct aie y a

eiobhw0m-egct1ao,>thecee"-ioesstarcnhp.hworiyaamcdi3l/tnw-r hc mlre iiitobeihxvc/rwh8f u9oteta o -l4ot cnul .ir l seouafyioorontg8tefbjl ybrpoL fibfk ityef,en l o-7ycr seeLme<-ae vdl-t,u-o o2la1r$s:oa,ua iya

&bp;s n